Tigecycline for the Treatment of Severe Clostridium difficile Infection

Future novel therapeutic agents forClostridium difficileinfection

(2010) Hoonmo L Koo et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

(2010) Stuart H. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Activity of tigecycline against multidrug-resistant clinical isolates of Clostridium spp. from Europe

(2010) Stephen P. Hawser   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole

(2010) Ching-Lan Lu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Is Repeat PCR Needed for Diagnosis of Clostridium difficile Infection?

(2010) R. F. Luo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST)

(2010) Elisabeth Nagy et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Intravenous Tigecycline as Adjunctive or Alternative Therapy for Severe RefractoryClostridium difficileInfection

(2009) Bjorn L. Herpers et al.   CLINICAL INFECTIOUS DISEASES

High Frequency of Rifampin Resistance Identified in an EpidemicClostridium difficileClone from a Large Teaching Hospital

(2009) Scott R. Curry et al.   CLINICAL INFECTIOUS DISEASES

In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993–2007 in Sweden

(2009) T. Norén et al.   CLINICAL MICROBIOLOGY AND INFECTION

Activity of tigecycline against recent European clinical isolates of Clostridium difficile

(2009) Stephen P. Hawser   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS